TRUQAP 200 mg/1

TRUQAP 200 mg is a film-coated tablet containing capivasertib, used for targeted therapy. Learn about its uses, effects, and precautions.

TRUQAP 200 mg is primarily used in targeted therapy for certain types of cancer. Capivasertib, the active ingredient, is designed to inhibit specific proteins involved in cancer cell growth. This medication is often used in combination with other treatments to manage specific conditions. Understanding what TRUQAP is used for involves recognizing its role in targeted cancer therapy.

Common effects of TRUQAP 200 mg may include fatigue, nausea, and diarrhea. Some individuals might experience appetite changes or skin reactions. These effects can vary widely among users, and it's important to monitor any unusual symptoms while taking this medication.

TRUQAP 200 mg should be handled with care, following the guidance of a healthcare professional. It is essential to store the medication properly and adhere to the prescribed regimen. Always inform your healthcare provider about any pre-existing conditions or other medications you are taking to avoid potential complications.

TRUQAP 200 mg may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. It's crucial to discuss all current medications with your healthcare provider to ensure safe and effective use of TRUQAP.